Pfizer has a diversified portfolio, including successful vaccines and promising new drugs. Read more to see why I upgrade PFE ...

Executives from Pfizer Inc and Amazon.com see opportunities for working with U.S. health secretary nominee Robert F. Kennedy ...

Guggenheim lowered the firm’s price target on Pfizer (PFE) to $33 from $35 and keeps a Buy rating on the shares. Pfizer will be releasing their ...

Fox News health commentator Dr. Kelly Powers was diagnosed with glioblastoma, an aggressive form of brain cancer, in July ...

Health care companies are taking a step back to better understand patients' experiences after a powerful U.S. health ...

We recently compiled a list of the 8 Best American Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

In a report released today, Umer Raffat from Evercore ISI maintained a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Shares of Pfizer Inc. PFE rose 1.44% to $26.10 Monday, on what proved to be an all-around rough trading session for the stock ...

The company’s collaboration with German biotech BioNTech (Nasdaq: BNTX) on Comirnaty (tozinameran), one of the first ...

Over the past month, shares of this drugmaker have returned -3.7%, compared to the Zacks S&P 500 composite's +2.9% change. During this period, the Zacks Large Cap Pharmaceuticals industry, which ...

With a market cap of $144.8 billion, New York-based Pfizer Inc. (PFE) is a global biopharmaceutical company that discovers, ...